Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population

Int J Cancer. 1996 Mar 15;65(6):740-5. doi: 10.1002/(SICI)1097-0215(19960315)65:6<740::AID-IJC5>3.0.CO;2-Z.

Abstract

Human T and natural-killer (NK) cells, that are thought to be the major cytotoxic effector-cell populations in the defence against neoplastic cells, were isolated from blood and decidua in order to analyze their expression of carcinoembronic-antigen-(CEA)-family-member proteins. Biliary glycoprotein (BGP,CD66a) was the only member of the carcinoembryonic antigen family detected. While freshly isolated T-cells expressed low amounts of BGP, freshly isolated NK cells were negative. After in vitro stimulation for 3 days, T cells up-regulated their BGP expression and a sub-group of NK cells (CD16- CD56+), known to predominate in decidua revealed de novo expression of BGP. In contrast, stimulated CD16+ CD56+ NK cells, which occur exclusively in the blood, remained negative. The expression of BGP could be shown on the protein level by using a panel of 12 well-defined MAbs and on the transcription level in rt-PCR and subsequent oligonucleotide hybridization. Interestingly, rIL-2-stimulated T cells expressed 3-fold higher levels of BGP compared with those seen after stimulation with phytohemagglutinin (PHA). PHA, on the other hand, induced a higher expression of HLA-DR, an activation marker of T cells. The differential regulation implies a distinct function of BGP and HLA-DR.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / biosynthesis
  • Antigens, CD / blood
  • Antigens, Differentiation / biosynthesis
  • Antigens, Differentiation / blood
  • Base Sequence
  • CD56 Antigen / biosynthesis
  • CD56 Antigen / blood
  • Carcinoembryonic Antigen / biosynthesis
  • Carcinoembryonic Antigen / genetics
  • Cell Adhesion Molecules
  • Decidua / metabolism
  • Epitopes
  • Female
  • Glycoproteins / biosynthesis*
  • Glycoproteins / genetics
  • Glycoproteins / immunology
  • Humans
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / metabolism*
  • Lymphocyte Activation / drug effects
  • Molecular Sequence Data
  • Phytohemagglutinins / pharmacology
  • Receptors, IgG / analysis
  • Receptors, IgG / biosynthesis
  • Stimulation, Chemical
  • T-Lymphocyte Subsets / physiology*
  • T-Lymphocytes / metabolism*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CD56 Antigen
  • CD66 antigens
  • Carcinoembryonic Antigen
  • Cell Adhesion Molecules
  • Epitopes
  • Glycoproteins
  • Interleukin-2
  • Phytohemagglutinins
  • Receptors, IgG